Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic...

Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and
Metabolic Syndrome
Japanese and Other Ethnic Minorities at Increased Risk

BALTIMORE, April 4, 2008 /PRNewswire/ -- Newly published data by Dr. J.
Barthelow Classen in The Open Endocrinology Journal shows a 50% reduction of
type 2 diabetes occurred in Japanese children following the discontinuation of
a single vaccine, a vaccine to prevent tuberculosis. This decline occurred at
a time when there is a global epidemic of type 2 diabetes and metabolic
syndrome, which includes obesity, altered blood cholesterol levels, high blood
pressure, and increased blood glucose resulting from insulin resistance.
Classen proposes a new explanation for the epidemic of both insulin
dependent diabetes (type 1 diabetes), which has previously been shown to be
caused by vaccines and non insulin dependent diabetes (type 2 diabetes). Upon
receipt of vaccines or other strong immune stimulants some individuals develop
a hyperactive immune system leading to autoimmune destruction of insulin
secreting cells. Other individuals produce increased cortisol, an immune
suppressing hormone, to suppress the vaccine induced inflammation. The
increased cortisol leads to type 2 diabetes and metabolic syndrome. Japanese
children have increased cortisol secretion following immunization compared to
White children and this explains why Japanese have a relative high rate of
type 2 diabetes but low rate of insulin dependent diabetes compared to Whites.
The lower cortisol response attributed to type 1 diabetes and the higher
cortisol response attributed to type 2 diabetes explains why type 1 diabetics
are generally leaner than type 2 diabetics since elevated cortisol causes
weight gain.
"The current data shows that vaccines are much more dangerous than the
public is lead to believe and adequate testing has never been performed even
in healthy subjects to indicate that there is an overall improvement in health
from immunization. The current practice of vaccinating diabetics as well as
their close family members is a very risky practice," says Dr. J. Barthelow
Classen.
Classen's research has become widely accepted. To view the published
papers and to find out the latest information on the effects of vaccines on
autoimmune diseases including insulin dependent diabetes visit the Vaccine
Safety Web site www.vaccines.net/newpage11.htm
Classen Immunotherapies, Inc.
6517 Montrose Avenue Baltimore, MD 21212 U.S.A.
Tel: (410) 377-8526 Classen@vaccines.net
vaccines.net


SOURCE Classen Immunotherapies, Inc.

Classen Immunotherapies, Inc., +1-410-377-8526, Classen@vaccines.net